Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 1/20 | 0.51 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | CHRM2 | P08172 | 10/20 | 0.47 |
| ▸ | CHRM3 | P20309 | 10/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.42 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.42 |
| ▸ | HRH1 | P35367 | 1/20 | 0.42 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.42 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.42 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.42 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9193099 | 0.98 | MAPT (0.52) | KEAP1NFE2L2MAPTNPSR1SMN1; SMN2 | |
| SCHEMBL6589615 | 0.96 | KEAP1 (0.47) | KEAP1NFE2L2MAPTNPSR1SMN1; SMN2 | |
| SCHEMBL609929 | 0.92 | MEN1 (0.43) | KEAP1NFE2L2MAPTNPSR1SMN1; SMN2 | |
| SCHEMBL2062914 | 0.81 | KEAP1 (0.56) | KEAP1NFE2L2MAPTNPSR1SMN1; SMN2 | |
| SCHEMBL2062409 | 0.81 | KEAP1 (0.56) | KEAP1NFE2L2MAPTNPSR1SMN1; SMN2 | |
| SCHEMBL27821813 | 0.80 | KEAP1 (0.54) | KEAP1NFE2L2MAPTNPSR1SMN1; SMN2 | |
| SCHEMBL27700604 | 0.80 | KEAP1 (0.54) | KEAP1NFE2L2MAPTNPSR1SMN1; SMN2 | |
| SCHEMBL12531908 | 0.80 | MAPT (0.52) | KEAP1NFE2L2MAPTNPSR1SMN1; SMN2 | |
| SCHEMBL198459 | 0.80 | MAPT (0.52) | KEAP1NFE2L2MAPTNPSR1SMN1; SMN2 | |
| SCHEMBL552275 | 0.78 | MEN1 (0.36) | KEAP1NFE2L2MAPTNPSR1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116836104-A | Blue light induced method for hydrogen trifluoromethyl of alkynyl compound | 湖南大学 | 2023-10-03 | — | — | CN | disclosed |
| US-20080280883-A1 | Muscarinic Receptor Antagonists | RANBAXY LABORATORIES LIMITED (IN) | 2008-11-13 | — | — | US | disclosed |
| EP-1794161-A2 | MUSCARINIC RECEPTOR ANTAGONISTS | Ranbaxy Laboratories Limited (IN) | 2007-06-13 | — | — | EP | disclosed |
| WO-2006032994-A2 | MUSCARINIC RECEPTOR ANTAGONISTS | RANBAXY LABORATORIES LIMITED (IN) | 2006-03-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080280883-A1 | Muscarinic Receptor Antagonists | CHRM3, CHRM5, CHRM2 | KEAP1 1713/4885NFE2L2 4205/4885MAPT 3314/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.